Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Hepatology. 2011 Sep 6;54(4):1388–1397. doi: 10.1002/hep.24518

Figure 6.

Figure 6

Evaluation of MTA1 expression in O. viverrini-induced human cholangiocarcinomas. (A) Immunohistochemical analysis of MTA1 in bile duct hyperplasia, early stage cholangiocarcinoma, and advanced-stage cholangiocarcinoma. (B) Representative examples of subcellular localization of MTA1 in the nuclear, cytolasmic, and both compartments (Cyto + Nuclear). (C) Representative examples of MTA1 immunoreactivity in the stromal compartment; arrowed indicate examples of MTA1-positive, stromal fibroblasts. For each situation, consecutive paraffin sections were stained with Haematoxylin and Eosin (H&E) (left panels) and with anti MTA1 antibody (right panels).